<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03222141</url>
  </required_header>
  <id_info>
    <org_study_id>2010-12-S3HR/NR7</org_study_id>
    <nct_id>NCT03222141</nct_id>
  </id_info>
  <brief_title>The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - High Risk and Nested Registry 7</brief_title>
  <acronym>PII S3HR/NR7</acronym>
  <official_title>Edwards SAPIEN 3 Transcatheter Heart Valve Therapy for High Risk and Inoperable Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN
      3 transcatheter heart valve and delivery systems which are intended for use in patients with
      symptomatic, calcific, severe aortic stenosis, and are in high risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, non-randomized, multi-center trial for patients undergoing aortic
      valve replacement with the Edwards SAPIEN 3 THV for severe aortic stenosis. Patient cohorts
      will include those inoperable and those considered as a high surgical risk (STS ≥8%). The
      study also includes NR7 patients (patients with a 20mm vessel size).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Composite Rate of All-cause Mortality, All Stroke, and AI ≥ Moderate</measure>
    <time_frame>30 Days</time_frame>
    <description>The composite rate of all-cause mortality, all stroke, and AI ≥ moderate for patients deemed as 'high risk' using the Edwards SAPIEN 3 transcatheter heart valve (THV).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Major Vascular Complications</measure>
    <time_frame>30 Days</time_frame>
    <description>The rate of major vascular complications at 30 days post implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Aortic Insufficiency at 30 Days</measure>
    <time_frame>30 Days</time_frame>
    <description>The proportion of patients with aortic insufficiency ≥ moderate at 30 days.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">583</enrollment>
  <condition>Symptomatic Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>SAPIEN 3™ valve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAVR Implantation of the THV Prosthesis</intervention_name>
    <description>Patients with TAVR implantation</description>
    <arm_group_label>SAPIEN 3™ valve</arm_group_label>
    <other_name>SAPIEN 3™valve</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient has senile degenerative aortic valve stenosis with echocardiographically
             derived criteria: mean gradient &gt;40 mmHg or jet velocity greater than 4.0 m/s and an
             initial aortic valve area (AVA) of ≤0.8 cm2 or indexed EOA &lt; 0.5 cm2/m2. Qualifying
             echo must be within 60 days of the date of the procedure.

          2. Patient is symptomatic from his/her aortic valve stenosis, as demonstrated by NYHA
             Functional Class II or greater.

          3. The heart team agrees (and verified in the case review process) that valve
             implantation will likely benefit the patient.

          4. The study patient or the study patient's legal representative has been informed of the
             nature of the study, agrees to its provisions and has provided written informed
             consent as approved by the Institutional Review Board (IRB) of the respective clinical
             site.

          5. The study patient agrees to comply with all required post-procedure follow-up visits
             including annual visits through 5 years and analysis close date visits, which will be
             conducted as a phone follow-up.

          6. STS &gt; 8

        Exclusion Criteria:

          1. Pre-existing mechanical or bioprosthetic valve in any position.

          2. Active bacterial endocarditis within 6 months (180 days) of procedure.

          3. Echocardiographic evidence of intracardiac mass, thrombus or vegetation.

          4. Any therapeutic invasive cardiac procedure resulting in a permanent implant that is
             performed within 30 days of the index procedure. Implantation of a permanent pacemaker
             or ICD is not considered exclusion criteria.

          5. Aortic valve is a congenital unicuspid or congenital bicuspid valve, or is
             non-calcified.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin B Leon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center DC</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morton Plant Hospital</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prairie Education and Research Cooperative</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Health-Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University - Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nebraska Heart Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Hospital</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence St.Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Heart, PLLC</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical City Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital, Providence Health Care</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2017</study_first_posted>
  <results_first_submitted>December 7, 2017</results_first_submitted>
  <results_first_submitted_qc>July 17, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 14, 2018</results_first_posted>
  <last_update_submitted>September 10, 2019</last_update_submitted>
  <last_update_submitted_qc>September 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sapien 3</keyword>
  <keyword>Transfemoral</keyword>
  <keyword>Transapical</keyword>
  <keyword>Transaortic</keyword>
  <keyword>TAVI</keyword>
  <keyword>Aortic Stenosis</keyword>
  <keyword>THV</keyword>
  <keyword>Aortic Valve</keyword>
  <keyword>Transcatheter Heart Valve</keyword>
  <keyword>TAVR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SAPIEN 3™ Valve</title>
          <description>TAVR Implantation of the THV Prosthesis: Patients with TAVR implantation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="583"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="565"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SAPIEN 3™ Valve</title>
          <description>TAVR Implantation of the THV Prosthesis: Patients with TAVR implantation</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="583"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82.6" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="245"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="338"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>STS score</title>
          <description>The Society of Thoracic Surgeons (STS) Score measures patient risk of mortality or morbidity at the time of cardiovascular surgery on a scale that ranges from 0% to 100%, with higher numbers indicating greater risk.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.6" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NYHA III/IV</title>
          <description>New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I-IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Coronary artery disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Composite Rate of All-cause Mortality, All Stroke, and AI ≥ Moderate</title>
        <description>The composite rate of all-cause mortality, all stroke, and AI ≥ moderate for patients deemed as 'high risk' using the Edwards SAPIEN 3 transcatheter heart valve (THV).</description>
        <time_frame>30 Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SAPIEN 3™ Valve</title>
            <description>TAVR Implantation of the THV Prosthesis: Patients with TAVR implantation</description>
          </group>
        </group_list>
        <measure>
          <title>The Composite Rate of All-cause Mortality, All Stroke, and AI ≥ Moderate</title>
          <description>The composite rate of all-cause mortality, all stroke, and AI ≥ moderate for patients deemed as 'high risk' using the Edwards SAPIEN 3 transcatheter heart valve (THV).</description>
          <units>percentage of patients</units>
          <param>Number</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="583"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" lower_limit="5.1" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Major Vascular Complications</title>
        <description>The rate of major vascular complications at 30 days post implantation</description>
        <time_frame>30 Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>SAPIEN 3™ THV</title>
            <description>TAVR Implantation of the THV Prosthesis: Patients with TAVR implantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Major Vascular Complications</title>
          <description>The rate of major vascular complications at 30 days post implantation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="583"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Aortic Insufficiency at 30 Days</title>
        <description>The proportion of patients with aortic insufficiency ≥ moderate at 30 days.</description>
        <time_frame>30 Days</time_frame>
        <population>Echo data was available only for 532 patients.</population>
        <group_list>
          <group group_id="O1">
            <title>SAPIEN 3™ Valve</title>
            <description>TAVR Implantation of the THV Prosthesis: Patients with TAVR implantation</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Aortic Insufficiency at 30 Days</title>
          <description>The proportion of patients with aortic insufficiency ≥ moderate at 30 days.</description>
          <population>Echo data was available only for 532 patients.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="532"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>the adverse event data was collected over 30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>SAPIEN 3™ THV</title>
          <description>TAVR Implantation of the THV Prosthesis: Patients with TAVR implantation.
High risk cohort</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="232" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia/Hemolytic anemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina/Cardiac chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Aortic insufficiency/Regurgitation PV leak - Non structural dysfunction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Aortic insufficiency/Regurgitation non valvular cause</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Arrhythmia/Conduction system injury (defect)</sub_title>
                <counts group_id="E1" events="108" subjects_affected="105" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Heart failure/CHF/Low output failure</sub_title>
                <counts group_id="E1" events="31" subjects_affected="29" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>MI</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastro Intestinal event - Non-hemorrhagic</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding - Hemorrhage</sub_title>
                <counts group_id="E1" events="44" subjects_affected="41" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Miscellaneous - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection - Access site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Infection - Bacteremia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Infection - Other</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Infection - Respiratory infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Infection - Sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Access site and access related vascular injury - Aortic root rupture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Dissection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Distal embolization (noncerebral) from vascular sou</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Failure of percutaneous access site closure</sub_title>
                <description>Resulting in intervention</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Hematoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Other</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Pseudoaneurysm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Thoracic aortic dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Access site and access related vascular injury - Ventricular rupture (Apical rupture)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Device embolization</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Device migration/malposition requiring intervention</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Miscellaneous - Fall</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Musculoskeletal - Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Any Adverse Event</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Ischemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Neurological - Undetermined stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Unknown cause of death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Exercise intolerance or weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal - Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Miscellaneous - Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Neurological - Dysphasia/Aphasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Neurological - Hemiparesis (One sided body weakness)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Neurological - Ischemic stroke</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Neurological - Sensory loss on one side of body</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Neurological - TIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Mental state change (not neurological) - Confusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Mental state change (not neurological) - Depression</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Genito-Urinary event - Non-hemorrhagic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Infection - Urinary tract infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Renal insufficiency or renal failure</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory event - Dyspnea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Respiratory event - Other</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Respiratory event - Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Respiratory event - Pulmonary effusion</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Respiratory event - Respiratory failure</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Thromboembolic event</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Vascular complication - Non-access related</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="397" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia/Hemolytic anemia</sub_title>
                <counts group_id="E1" events="54" subjects_affected="54" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="40" subjects_affected="40" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia/Conduction system injury (defect)</sub_title>
                <counts group_id="E1" events="146" subjects_affected="128" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Heart failure/CHF/Low output failure</sub_title>
                <counts group_id="E1" events="41" subjects_affected="41" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Abnormal lab value</sub_title>
                <counts group_id="E1" events="82" subjects_affected="71" subjects_at_risk="583"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="45" subjects_affected="41" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal insufficiency or renal failure</sub_title>
                <counts group_id="E1" events="54" subjects_affected="54" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding - Hemorrhage</sub_title>
                <counts group_id="E1" events="126" subjects_affected="118" subjects_at_risk="583"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tenley Koepnick</name_or_title>
      <organization>Edwards Life Sciences</organization>
      <phone>949-250-6504</phone>
      <email>Tenley_Koepnick@Edwards.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

